Does Record 2025 Results And Margin Guidance Change The Bull Case For Abercrombie & Fitch (ANF)?

Abercrombie & Fitch Co. Class A -2.13%

Abercrombie & Fitch Co. Class A

ANF

92.25

-2.13%

  • In early March 2026, Abercrombie & Fitch Co. reported past fourth-quarter and full-year 2025 results with record sales of US$1,669.8 million and US$5,266.29 million respectively, even as net income eased to US$172.13 million for the quarter and US$506.92 million for the year, alongside ongoing share repurchases and new store expansion plans.
  • The company coupled this performance with 2026 guidance targeting low single-digit net sales growth, double-digit operating margins of about 12.0% to 12.5%, and continued earnings per diluted share in the US$10.20 to US$11.00 range, signalling management’s confidence while it invests in global growth and returns cash to shareholders.
  • Next, we’ll examine how this double-digit operating margin outlook and continued buybacks interact with Abercrombie & Fitch’s existing investment narrative.

Invest in the nuclear renaissance through our list of 87 elite nuclear energy infrastructure plays powering the global AI revolution.

Abercrombie & Fitch Investment Narrative Recap

To own Abercrombie & Fitch, you need to believe its brand refresh and omnichannel model can support healthy margins even as tariffs and shifting fashion tastes bite into profitability. The latest record sales and 2026 guidance for low single digit growth with double digit operating margins support the near term catalyst of margin resilience, but they do not remove the key risk that higher costs and promotional intensity could still pressure earnings if demand softens.

The most relevant recent announcement is the completion of US$450 million in share buybacks, retiring about 11.2% of shares. Combined with guidance for US$10.20 to US$11.00 in 2026 diluted EPS and 12.0% to 12.5% operating margins, this capital return profile matters for the story because it amplifies per share outcomes if the business holds its margin ground, but also magnifies the impact if tariffs and physical store expansion weigh more heavily on profits.

Yet behind the upbeat 2026 margin outlook, investors should be aware of how rising fixed costs from new stores could interact with...

Abercrombie & Fitch's narrative projects $5.8 billion revenue and $489.4 million earnings by 2028. This requires 4.3% yearly revenue growth and an earnings decrease of about $51.6 million from $541.0 million today.

Uncover how Abercrombie & Fitch's forecasts yield a $120.78 fair value, a 48% upside to its current price.

Exploring Other Perspectives

ANF 1-Year Stock Price Chart
ANF 1-Year Stock Price Chart

Before this earnings release, the most optimistic analysts were assuming revenue around US$5.9 billion and earnings near US$552 million by 2028, which is far more upbeat than consensus and leans heavily on faster international and digital growth. Compared with the concerns about heavier in store expansion and promotions, that bullish view may look either more achievable or more stretched after this news, so it is worth weighing how your own expectations stack up against both ends of the analyst range.

Explore 13 other fair value estimates on Abercrombie & Fitch - why the stock might be worth just $98.99!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

  • A great starting point for your Abercrombie & Fitch research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
  • Our free Abercrombie & Fitch research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Abercrombie & Fitch's overall financial health at a glance.

Contemplating Other Strategies?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

  • Find 48 companies with promising cash flow potential yet trading below their fair value.
  • AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
  • The future of work is here. Discover the 30 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.